Table 1.
Guidelines | Year | Committee | Recommendation |
---|---|---|---|
Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. | 2013 | The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis | Trauma patients who present with severe bleeding, characterized by a marked hyperfibrinolytic state could be treated with antifibrinolytic agents (moderate quality). |
A practical guideline for the hematological management of major haemorrhage. | 2015 | British Committee for Standards in Haematology | Adult trauma patients with, or at risk of, major hemorrhage, should be given TXA as soon as possible after injury (grade 1A). |
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. | 2016 | The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma | TXA administration was recommended as early as possible to a trauma patient who is bleeding or at risk of significant hemorrhaging (grade 1A) |
Consider administration of the first dose of TXA en route to the hospital (grade 2C) | |||
Major trauma: assessment and initial management. | 2016 | National Clinical Guideline Centre | Use intravenous TXA as soon as possible in patients with major trauma and active or suspected active bleeding. |
Do not use intravenous TXA more than 3 h after injury in patients with major trauma unless there is evidence of hyperfibrinolysis. |
DIC disseminated intravascular coagulation, TXA tranexamic acid